7 recruiting. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 7 |
| Phase 3 | 1 | Recruiting 1 |
Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjunctive Fludrocortisone in Septic Shock Fludrocortisone 100 mcg daily, Placebo - Sepsis, Septic Shock | Phase 2 | Recruiting | Chinese University of Hong Kong | 32 | 2026-04-01 | 2026-06-02 |
| Early Methylene Blue in the Microhemodynamics of Septic Patients Methylene blue infusion - Septic Shock, Hypoperfusion | Phase 2 / Phase 3 | Recruiting | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | 50 | 2026-01-09 | 2026-03-27 |
| Study SOLACE SEPSIS Sodium Lactate, 3% NaCl - Septic Shock, Intracranial Hypertension | Phase 2 | Recruiting | University Hospital Pilsen | 40 | 2024-11-24 | 2026-04-14 |
| Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock Allogeneic umbilical cord-derived human mesenchymal stromal cells, Placebo - Septic Shock, Sepsis | Phase 2 | Recruiting | Ottawa Hospital Research Institute | 296 | 2024-02-14 | 2024-12-05 |
| Therapeutic Plasma Exchange in Septic Shock: A Pilot Study Therapeutic Plasma Exchange - Septic Shock | Phase 2 | Recruiting | University of Manitoba | 80 | 2023-06-01 | 2025-08-17 |
| Xanthohumol as an Adjuvant in the Treatment of Septic Shock Xanthohumol - Septic Shock, Pneumonia | Phase 2 | Recruiting | Medical University of Lublin | 50 | 2023-01-09 | 2025-07-04 |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis Pentaglobin®/Standard of Care - Peritonitis, Sepsis | Phase 2 | Recruiting | RWTH Aachen University | 200 | 2017-11-20 | 2026-06-11 |
Shock, Septic (7) · Sepsis (4) · Inflammation (2) · Infections (1) · Intracranial Hypertension (1) · Pathologic Processes (1) · Peritonitis (1) · Pneumonia (1) · Shock (1) · Systemic Inflammatory Response Syndrome (1)
Pathological Conditions, Signs and Symptoms (7) · Infections (6) · Pathologic Processes (6) · Shock (6) · Systemic Inflammatory Response Syndrome (6) · Inflammation (5) · Sepsis (3) · Brain Diseases (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Intraabdominal Infections (1) · Lung Diseases (1) · Nervous System Diseases (1) · Peritoneal Diseases (1) · Respiratory Tract Diseases (1)
Fludrocortisone (1) · Methylene Blue (1) · Phenothiazines (1) · Plasma Exchange (1) · Sodium Lactate (1) · xanthohumol (1)
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva (1) · Chinese University of Hong Kong (1) · Medical University of Lublin (1) · Ottawa Hospital Research Institute (1) · RWTH Aachen University (1) · University Hospital Pilsen (1) · University of Manitoba (1)
Canada (2) · Austria (1) · Brazil (1) · Czechia (1) · Germany (1) · Hong Kong (1) · Poland (1)
Emily Rimmer, MD, MSc (1) · Gernot Marx, Univ.-Prof. (1) · Lauralyn McIntyre, MD (1) · Ryan Zarychanski, MD, MSc (1) · Wlodzimierz Plotek (1) · Wojciech Dabrowski, Prof (1)
PMID 15231405, PMID 16134000, PMID 21093515, PMID 21659748, PMID 23036432, PMID 24200239, PMID 24329115, PMID 28188927, PMID 28234482, PMID 29906742, PMID 30832742, PMID 33231055, PMID 33517187, PMID 34170599, PMID 34398408, PMID 34830015, PMID 35857130, PMID 36074228, PMID 36378586, PMID 36508996, PMID 37406514, PMID 37520007, PMID 37954118
2016 (1)